caretrace.iopowered by▸healthparse
SearchCohort Builder
Tools▾
KOL FinderTerritoriesDrug Compare
AI Query
Browse▾
By stateBy specialty
Pricing
SearchCohort BuilderToolsKOL FinderTerritoriesDrug CompareAI QueryBrowseBy stateBy specialtyPricing
PROVIDER PROFILE · NPI 1700036902

John KostevaMD

Hematology-OncologyPhiladelphia, PAI
CROSS-REFERENCE

Related data on other Healthparse brands

ProviderScore
OIG/SAM exclusion screening, sanctions history
© 2026 CareTrace
PricingContactPrivacyTerms
REFERRAL NETWORK

Where John Kosteva's patients come from & go

Directional shared-patient flow from Medicare claims — who sends patients to this provider (inbound) and where this provider's patients go next (outbound). 6 inbound referrers · 0 outbound destinations.

Receives referrals from
Inbound — who sends patients here
PhysicianPatientsVisits
SAVERINO, TATIANA17260
Quest Diagnostics Clinical Laboratories Inc
Clinical Laboratory · Norristown, PA
1376
Eduardo Mortani Barbosa
Diagnostic Radiology · Philadelphia, PA
1373
Evan Siegelman
Diagnostic Radiology · Philadelphia, PA
1259
Ana Kolansky
Diagnostic Radiology · Philadelphia, PA
1147
PAPANICOLAOU, NICHOLAS1149
Refers patients to
Outbound — where patients go next
No outbound pairs above the suppression threshold.
Source: CMS Physician Shared Patient Patterns (30-day window, Medicare FFS). Direction = a beneficiary seen by the first provider, then the second, within 30 days; a proxy for referral, not a documented referral. Pairs with fewer than 11 shared beneficiaries are suppressed.
PRESCRIBING · PART D · 2024
Total Rx claims
605
Beneficiaries
—
Total drug cost
$2.3M
Distinct drugs
23
Brand share
41.7%
Top prescribed drugs
Ondansetron Hcl84 claims
Osimertinib Mesylate61 claims
Apixaban52 claims
Prednisone40 claims
Hydroxyurea33 claims
MEDICARE UTILIZATION · PART B · 2024
Total beneficiaries
745
Unique beneficiaries
—
Total services
1,870
Distinct HCPCS
6
Medicare payment
$105K
Peer benchmark
Q1
Q2
Q3
Q4
Q5
Total Medicare services vs. 417 Hematology-Oncology providers in PA — above median (cohort median 753).
QUALITY · MIPS · 2024
Final MIPS score
84.9
Quality
73.6
Cost
76.1
Improvement activities
40.0
Promoting interop.
100.0
Payment adjustment
0.42%
Group
INDUSTRY PAYMENTS · OPEN PAYMENTS · 2024
No data available for this provider in 2024.